A mark up for RNA epigenetics

As a field, RNA epigenetics is still in its infancy, though picking up pace as researchers translate lab findings to drug development. Two papers straddling academia and industry provide a new quantitative method that can improve decisions about what indications to pursue, and help companies assess how well their compounds are working.

While standard epigenetics -- which involves modifications of DNA -- is seeing its third wave of activity, RNA epigenetics has barely a decade of science to stand on (see “On Your Marks”)...